Daridorexant is a medicine used to treat insomnia, when it is hard to fall asleep or stay asleep. It is taken as a pill at night, shortly before bed. It works by blocking a brain signal called orexin that helps keep you awake.
Every report comes from a Lived member, sent anonymously.
Have you tried Quviviq (Daridorexant) for Insomnia?
Daridorexant, sold in the US as Quviviq, is a prescription sleep medicine for adults with insomnia: ongoing trouble falling asleep, staying asleep, or both. It is approved only for adults. Its safety and effectiveness in children and teenagers have not been established. It belongs to a newer group of medicines called orexin receptor antagonists, alongside suvorexant (Belsomra) and lemborexant (Dayvigo). For long-lasting insomnia, sleep guidelines recommend cognitive behavioral therapy for insomnia (CBT-I) as the first treatment. CBT-I is a structured program, in person or digital, that changes the habits and thoughts that keep people awake. A medicine like daridorexant can be offered when CBT-I has not helped enough, and US sleep specialists suggest pairing medicine with CBT-I rather than using medicine alone.
Orexins are chemical messengers made by a small group of brain cells. They help keep a person awake and alert, and their activity normally falls at night. Daridorexant blocks the receptors that orexins act on, which is thought to turn down the brain's drive to stay awake so that sleep can take over more easily. The medicine reaches its peak level in the blood within one to two hours, and the body clears half of it in about eight hours. That timing is why it needs a full night in bed: taken too late, enough can remain in the morning to cause drowsiness.
Daridorexant is a tablet taken by mouth no more than once a night, within 30 minutes of going to bed, and only when at least 7 hours remain before the planned wake-up time. It comes in 25 mg and 50 mg strengths, and the prescriber chooses which one to use. Taking it with or soon after a meal, especially a heavy one, can slow how quickly it helps you fall asleep. The highest dose is 25 mg for people with moderate liver disease and for people taking certain medicines that slow its breakdown (described under Interactions & Warnings). It is not recommended for people with severe liver disease. Age and kidney function do not change the dose. Taking more than prescribed, or a second dose in the night, raises the risk of being impaired the next day.
Headache and next-day sleepiness or tiredness are the most common side effects. Dizziness and nausea are less common. Drowsiness becomes more likely with age, and older adults in particular have a higher risk of falls, for example when getting up during the night. Some people have brief sleep paralysis (being unable to move or speak for up to a few minutes while falling asleep or waking), vivid or disturbing dream-like images at those same moments, or nightmares. Short spells of sudden leg weakness, lasting seconds to minutes, have also been reported with this group of medicines. These effects are uncommon, but they can be frightening and are worth telling the prescriber about. Like other sleep medicines, daridorexant can cause complex sleep behaviors: sleepwalking, driving, cooking, making phone calls or having sex while not fully awake, often with no memory of it afterward. This can happen after the first dose. If it happens, stop taking daridorexant and contact the prescriber right away. Worsening depression or new thoughts of suicide should also be reported to the prescriber promptly. Swelling of the face, lips, tongue or throat can signal a serious allergic reaction and needs emergency care.
People with narcolepsy, a sleep disorder that causes extreme daytime sleepiness, must not take daridorexant. Neither should anyone who has had an allergic reaction to it. Daridorexant slows brain activity, and its effects add to those of alcohol and other sedating medicines, such as opioid pain medicines, benzodiazepines (anti-anxiety and sleep medicines) and older tricyclic antidepressants. Avoid alcohol while taking it. Using it together with another insomnia medicine is not recommended, and the prescriber may need to adjust doses if another sedating medicine is needed. Even when taken as directed, it can impair next-morning driving: in a driving-simulator study, driving was worse the morning after the first dose, and some people stayed affected after several nights. Be cautious about driving or other tasks that need full alertness until you know how it affects you, and avoid them if you took it with less than a full night left. The liver breaks down daridorexant with an enzyme called CYP3A4. Medicines that strongly block this enzyme, such as the antifungal itraconazole, can raise daridorexant levels more than fivefold and should not be combined with it. Moderate blockers limit the dose to 25 mg. Medicines that speed the enzyme up, such as the antibiotic rifampin, can make it much less effective. Daridorexant can also raise levels of some other medicines, so ask a pharmacist to check all prescriptions, over-the-counter products and supplements. It is a Schedule IV controlled substance: at two to three times the highest dose, people who use sedatives recreationally rated its effects as similarly appealing to other sleep medicines. People with a past history of alcohol or drug misuse should discuss this with the prescriber. Anyone with breathing problems such as sleep apnea or COPD (chronic obstructive pulmonary disease) should mention them, since it has been studied in only some of these groups. There are no human data on use in pregnancy. Small amounts pass into breast milk, so a breastfed baby should be watched for unusual sleepiness.
In two three-month trials, people taking daridorexant fell asleep somewhat faster, spent less time awake during the night and reported more total sleep. People taking a placebo (a dummy pill) also improved, so the useful figure is the extra benefit. At 50 mg, people reported about 20 more minutes of sleep per night than with placebo and spent about 20 fewer minutes awake during the night. The 25 mg dose gave smaller gains. Effects were seen within the first month and held through three months. If sleep is no better after 7 to 10 days, or gets worse, the prescriber should look again for another medical or mental health condition behind the insomnia. European guidelines say orexin medicines can be used for up to three months, or longer for some people, and daridorexant was studied for up to a year. Stopping it did not cause withdrawal symptoms in trials, but some of the sleep difficulty tended to return in the following nights. In some people, drowsiness can linger for a few days after the last dose.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Quviviq (Daridorexant), what you've noticed, or ask the community a question.